7 employees
Boston Therapeutics develops and commercializes novel compounds for unmet medical needs in the areas of diabetes and inflammatory diseases.
2007
$500K
from 1 investors over 1 rounds
Boston Therapeutics, Inc. (OTCQB:BTHE) raised $500K on June 14, 2012
Investors: Advancis Pharmaceutical Corp